Authorities are investigating treatment of a quadriplegic man whose ... he opted for medical aid in dying rather than returning to the hospital when the injury progressed A quadriplegic man ...

Canadian Nuclear Isotope Council honours CNL, Sylvia Fedoruk Centre and Advanced Cyclotron Systems for first cyclotron irradiation of Radium-226 to produce Actinium-225 in Canada ...

Mansour is set to make medical history as the first person in the world to receive treatment for NARS1, a rare genetic disorder. (Juan Figueroa / Staff Photographer) An 11-year-old from Rowlett is ...

In 2018, he unveiled another facet of his artistic expression with his first solo art exhibition. The partnership between Nicholas Huxley and PNG Fashion Week underscores the platform’s ongoing ...

Icon will provide specialist radiation oncology services that complement Nuffield Health’s existing cancer care, ensuring patients receive seamless, high-quality treatment closer to home. The new ...

In Trump's First 100 Days, US Energy Dominance Plans ... energy sources that had enjoyed incentives and other favorable treatment under the prior administration," said David Amerikaner, partner ...

She’s now offering up to $100,000 of free transcranial magnetic stimulation (TMS) treatment to Denver first responders impacted by the cuts. “Leaving them behind was not an option, so the ...

LOS ANGELES — Living-related conjunctival limbal allograft should be first-line therapy for limbal ... Diagnoses were delayed or incorrect, or the wrong treatment was administered.

Dupixent Could Move the Needle on COPD Treatment Dupixent isn’t the first biologic tested in people with COPD. There are six biologics approved for asthma and almost all of them have been studied in ...

America First' Antitrust Enforcement Is Not Regulation, DOJ Official Says By Jody Godoy (Reuters) -The head of the U.S. Department of Justice's antitrust division laid out a vision for "America ...

InnoCare Pharma, a leading biopharmaceutical company, announced that its BTK inhibitor orelabrutinib received approval from the China National Medical Products Administration (NMPA) for the first-line ...